{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:13:44Z","timestamp":1790802824965,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijcard.2025.134050","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:59:34Z","timestamp":1764086374000},"page":"134050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Early combination therapy with trimetazidine rapidly improves symptoms and quality of life in patients recently diagnosed with stable angina: The COMBINE angina study"],"prefix":"10.1016","volume":"446","author":[{"given":"Mario","family":"Marzilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Henrique Wolff","family":"Gowdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Sobhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafidah Abu","family":"Bakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu","family":"Stoicescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2024","key":"10.1016\/j.ijcard.2025.134050_bb0005","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.134050_bb0010","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1093\/eurheartj\/ehae278","article-title":"Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines","volume":"45","author":"Boden","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.134050_bb0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/heartjnl-2018-314661","article-title":"Angina: contemporary diagnosis and management","volume":"106","author":"Ford","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2025.134050_bb0020","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2025.134050_bb0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ehjqcco\/qcae049","article-title":"Global burden of ischemic heart disease from 2022 to 2050: projections of incidence, prevalence, deaths, and disability-adjusted life years","volume":"11","author":"Shi","year":"2025","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes."},{"key":"10.1016\/j.ijcard.2025.134050_bb0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.134050_bb0035","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/jcm14041161","article-title":"The European Society of Cardiology 2024 guidelines on chronic coronary syndromes: a critical appraisal","volume":"14","author":"Ferrari","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2025.134050_bb0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs\u2013beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.134050_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/VHRM.S264130","article-title":"Targeting cardiac metabolic pathways: a role in ischemic management","volume":"16","author":"Yehualashet","year":"2020","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ijcard.2025.134050_bb0050","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme a thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2025.134050_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003495-199958010-00016","article-title":"A review of its use in stable angina pectoris and other coronary conditions","volume":"58","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2025.134050_bb0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00044011-199713010-00002","article-title":"Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina","volume":"13","author":"Michaelides","year":"1997","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ijcard.2025.134050_bb0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/hrt.78.4.353","article-title":"Combination treatment with trimetazidine and diltiazem in stable angina pectoris","volume":"78","author":"Manchanda","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2025.134050_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00129784-200303050-00007","article-title":"Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study","volume":"3","author":"Sellier","year":"2003","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ijcard.2025.134050_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40119-018-0110-5","article-title":"Clinical acceptability of trimetazidine modified-release 80 mg once daily versus trimetazidine modified-release 35 mg twice daily in stable angina pectoris","volume":"7","author":"Pozdnyakov","year":"2018","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.ijcard.2025.134050_bb0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s12325-018-0674-4","article-title":"The effectiveness of trimetazidine treatment in patients with stable angina pectoris of various durations: results from the CHOICE-2 study","volume":"35","author":"Glezer","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ijcard.2025.134050_bb0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40119-020-00174-7","article-title":"Effectiveness of trimetazidine in patients with stable angina pectoris of various durations: results from ODA","volume":"9","author":"Glezer","year":"2020","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.ijcard.2025.134050_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40119-021-00249-z","article-title":"Effectiveness and tolerability of trimetazidine 80 mg once daily in patients with stable angina uncontrolled with bisoprolol-based therapy: the modus vivendi observational study","volume":"11","author":"Lopatin","year":"2022","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.ijcard.2025.134050_bb0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.eurheartj.a014699","article-title":"The Total ischaemic burden European trial (TIBET): effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina","volume":"17","author":"Fox","year":"1996","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.134050_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0735-1097(95)00489-0","article-title":"Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris: results of the international Multicenter angina exercise (IMAGE) study","volume":"27","author":"Savonitto","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.134050_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0002-9149(97)00893-X","article-title":"Centralised European studies in angina research (CESAR) investigators. Amlodipine versus diltiazem as additional antianginal treatment to atenolol","volume":"81","author":"Knight","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2025.134050_bb0110","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCULATIONAHA.121.054567","article-title":"International observational analysis of evolution and outcomes of chronic stable angina: the multinational CLARIFY study","volume":"144","author":"Mesnier","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.134050_bb0115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Grading of angina pectoris","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.134050_bb0120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","article-title":"Development and validation of a short version of the Seattle angina questionnaire","volume":"7","author":"Chan","year":"2014","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2025.134050_bb0125","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/bcp.14193","article-title":"The medication adherence report scale: a measurement tool for eliciting patients\u2019 reports of nonadherence","volume":"86","author":"Chan","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2025.134050_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2022.01.056","article-title":"Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca registry for chronic angina) registry: a prospective, observational, nationwide study","volume":"352","author":"Orsini","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2025.134050_bb0135","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.134050_bb0140","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.134050_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003971","article-title":"Predicting the benefits of percutaneous coronary intervention on 1-year angina and quality of life in stable ischemic heart disease: risk models from the COURAGE trial (clinical outcomes utilizing revascularization and aggressive drug evaluation)","volume":"11","author":"Zhang","year":"2018","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2025.134050_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacc.2022.08.814","article-title":"Evolving management paradigm for stable ischemic heart disease patients: JACC review topic of the week","volume":"81","author":"Boden","year":"2023","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325010939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325010939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:57:24Z","timestamp":1768471044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325010939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"alternative-id":["S0167527325010939"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.134050","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early combination therapy with trimetazidine rapidly improves symptoms and quality of life in patients recently diagnosed with stable angina: The COMBINE angina study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.134050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134050"}}